CELLULAR BIOMEDICINE GROUP, INC. Increase (Decrease) in Other Deferred Liability
CELLULAR BIOMEDICINE GROUP, INC. reported Increase (Decrease) in Other Deferred Liability of $0 for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherDeferredLiability · last filed 2017-08-08
- CELLULAR BIOMEDICINE GROUP, INC. increase (decrease) in other deferred liability for the quarter ending 2017-06-30 was $0.00, a 100.00% decline year-over-year.
- CELLULAR BIOMEDICINE GROUP, INC. increase (decrease) in other deferred liability for the quarter ending 2017-03-31 was $0.00.
- CELLULAR BIOMEDICINE GROUP, INC. increase (decrease) in other deferred liability for the quarter ending 2016-06-30 was $886.25K.
- CELLULAR BIOMEDICINE GROUP, INC. increase (decrease) in other deferred liability for the quarter ending 2016-03-31 was -$1.13M.
| Period end | Increase (Decrease) in Other Deferred Liability 3 month | Increase (Decrease) in Other Deferred Liability 6 month |
|---|---|---|
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $0.00 10-Q · filed 2017-08-08 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-08 | |
| 2016-06-30 | $886.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$242.27K 10-Q · filed 2017-08-08 |
| 2016-03-31 | -$1.13M 10-Q · filed 2017-05-08 | |
| 2015-03-31 | $0.00 10-Q · filed 2016-05-09 |